ÐÓ°ÉÖ±²¥ns may be missing out on new diabetes treatments

Friday, 17 March 2017

A free public lecture being held at the ÐÓ°ÉÖ±²¥ of Adelaide will present the latest research findings into new treatments for type 2 diabetes, which have major implications for effective management.

A leading international researcher is concerned that ÐÓ°ÉÖ±²¥ns may not be reaping the benefits of these potentially life-altering treatments.

Professor Michael Nauck is a world leader in diabetes research and a practicing 'diabetologist’. He's the Head of Clinical Research at the Diabetes Division, Medical Department, St Josef-Hospital (Ruhr-ÐÓ°ÉÖ±²¥ Bochum) in Bochum, Germany.

On Tuesday 21 March, Professor Nauck will deliver the at the ÐÓ°ÉÖ±²¥ of Adelaide: New treatments for type 2 diabetes to decrease the risk of heart disease and prolong life.

In his lecture, Professor Nauck will discuss research into type 2 diabetes that he has conducted over more than 25 years. He was the first researcher to recognise the potential of the hormone glucagon-like peptide-1 (GLP-1) for lowering the elevated blood glucose in people with type 2 diabetes. Drugs that act via GLP-1 are now used widely.

"Our most recent research has shown that, in people with type 2 diabetes, these drugs may also reduce the risk of heart disease and other metabolic conditions," Professor Nauck says.

"What concerns me is that drugs offering potentially clear benefits to ÐÓ°ÉÖ±²¥n patients with type 2 diabetes may not be readily available to them. This is partly because of a lack of drug approval, and partly because some drugs are not appropriately reimbursed under the Pharmaceutical Benefits Scheme.

"In my opinion, the choice of medication – and its accessibility to the public – should be based primarily on scientific evidence. And despite strong scientific evidence for the use of these drugs, ÐÓ°ÉÖ±²¥ appears to be lagging behind many other countries in its treatment of patients with type 2 diabetes," he says.

WHAT: Northern Communities Public Lecture: New treatments for type 2 diabetes to decrease the risk of heart disease and prolong life, by Professor Michael Nauck
WHERE: Florey lecture theatre, Medical School North building, ÐÓ°ÉÖ±²¥ of Adelaide, off Frome Road, Adelaide
WHEN: 5.30-6.30pm, Tuesday 21 March 2017
COST: Free and open to all –

The Northern Communities Lecture is hosted by the Faculty of Health and Medical Sciences, ÐÓ°ÉÖ±²¥ of Adelaide.

 

Contact details

Mr David Ellis
Email: david.ellis@adelaide.edu.au
Website: /newsroom/
Deputy Director, Media and Corporate Relations
External Relations
The ÐÓ°ÉÖ±²¥ of Adelaide
Business: +61 8 8313 5414
Mobile: +61 (0)421 612 762